There have been nearly $70 billion worth of deals in the pharmaceutical industry in 2008, almost double the value of last year. Eklavya Gupte investigates the reasons why there is so much activity and finds out how IP is driving the deals
Liu Shen & Associates, Beijing
Ernest Gutmann-Yves Plasseraud SAS, Lyon
Anand and Anand, New Delhi
September / October 2019
Should I stay or should I go? Private practice v in-house
In-house or private practice? It’s a question many lawyers and attorneys will probably ask themselves at some stage in their career, as Managing IP finds out
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2019 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International